SAN DIEGO, May 3 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX - News) today announced its financial results for the quarter ended March 31, 2007. For the first quarter of 2007, the Company reported a net loss of $25.7 million, or $0.68 per share compared with a net loss of $25.9 million, or $0.69 per share, for the same period in 2006.
